Proactive Investors - Run By Investors For Investors

THC Global's Canadian division boosts revenue 22% in March quarter

Having secured a substantial growing capacity over two sites and an industry-leading pharmaceuticals bio-manufacturing facility, THC Global is in a prime position to service domestic patients and the export market.
Cannabis plants
THC Global is delivering high-quality medicinal cannabis products to Australian patients

THC Global Group Ltd's (ASX:THC) Canadian hydroponics equipment division Crystal Mountain increased revenue in the March quarter primarily due to stronger sales in the lighting and lighting equipment product ranges.

Crystal Mountain grew revenue to $991,000, a 22% increase on the previous quarter. 

New distribution agreements

The division is also securing distribution agreements within Canada and has expanded into Europe and the United Kingdom.

READ: THC Global Group expands into Asia with partnership

As these distribution agreements are settled and products come on sale, the company expects to see stronger sales in these regions.

Expanded product range

Crystal Mountain has expanded its product range through distributing new products imported from partners across Canada, and soon internationally.

The division is also exploring new sales channels including online cannabis-focused offerings targeted to the micro-cultivator market, which is rapidly increasing in Canada.

THC Global chief executive officer Ken Charteris said: “We are pleased to see our hydroponics equipment division continue to grow, particularly through our partnership strategy as we are able to both expand our product offering and broaden our market reach - both of which are core drivers of revenue growth.”

READ: THC Global Group opens SPP and notes near term milestones

Earlier this month THC Global opened a share purchase plan offering shareholders to apply for up to $15,000 worth of additional shares at 50 cents each.

The company also released its April 2019 briefing note, which highlighted the near-term outlook for the company including the receipt of final Australian cannabis licenses and permits enabling two manufacturing facilities and cultivation sites.

Near-term outlook

It also listed signing key offtake agreements for products and securing cannabis supply through domestic production in its near-term outlook.

In addition to its core medicinal cannabis business, THC Global owns two Canadian companies - Crystal Mountain Products and Vertical Canna Inc.

Crystal Mountain is a revenue-generating global hydroponics retailer and distributor of equipment, material, and nutrients to cannabis growers and producers.

Vertical Canna is an investment vehicle through which THC Global intends to build, through acquisitions and strategic partnerships, a vertically integrated Canadian cannabis producer and retailer.

View full THC profile View Profile

THC Global Group Ltd Timeline

Related Articles

June 27 2018
Lancor Scientific is aiming to carry out an initial coin offering by issuing Medici, a new currency based on Ethereum to help Tumour Trace to fund further development
Empty lab
September 19 2018
Management has made some tough decisions, cutting the cost base, since a disappointing first-half performance and expects the benefits to really kick in next year
February 26 2019
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use